ERBB2 and neoplasm: Studies have shown that an increase in Notch1 and Notch3 is associated with lower DFS in triple-negative and HER-2+ tumors while blockade of Notch 2 and 3 can reduce tumor growth and the frequency of tumor cell initiation (153–155).